Patients with Keshan Disease typically present with symptoms related to heart failure. These may include fatigue, shortness of breath, swelling in the legs and abdomen, and irregular heartbeats. In severe cases, it can lead to sudden cardiac arrest. The disease can manifest in acute, subacute, or chronic forms, with varying degrees of severity and progression.

Diagnosing Keshan Disease involves a combination of clinical evaluation, laboratory tests, and imaging studies. Blood tests may reveal low selenium levels, while an echocardiogram can assess heart function and structure. Additional tests, such as an electrocardiogram (ECG) and chest X-ray, may be used to evaluate heart rhythm and detect fluid accumulation in the lungs.

The primary treatment for Keshan Disease is selenium supplementation, which can help restore normal heart function and prevent further damage. In addition to selenium, patients may require medications to manage heart failure symptoms, such as diuretics, beta-blockers, and ACE inhibitors. In severe cases, advanced interventions like pacemaker implantation or heart transplantation may be necessary.

The prognosis for Keshan Disease varies depending on the severity of the condition and the timeliness of treatment. Early intervention with selenium supplementation can lead to significant improvement and even full recovery. However, if left untreated, the disease can progress to severe heart failure and increase the risk of sudden cardiac death.

Keshan Disease is primarily caused by a deficiency in selenium, an essential trace element that plays a crucial role in antioxidant defense and thyroid hormone metabolism. The deficiency is often due to low selenium content in the soil, which affects the selenium levels in locally grown food. Genetic factors and viral infections have also been suggested as potential contributors to the disease.

Keshan Disease is most prevalent in certain rural areas of China, where the soil is deficient in selenium. It has also been reported in other parts of Asia and Africa with similar soil conditions. The disease predominantly affects children and women of childbearing age, although it can occur in any demographic group.

The pathophysiology of Keshan Disease involves oxidative stress and damage to heart muscle cells due to selenium deficiency. Selenium is a key component of glutathione peroxidase, an enzyme that protects cells from oxidative damage. Without adequate selenium, the heart becomes vulnerable to oxidative stress, leading to inflammation, cell death, and impaired cardiac function.

Preventing Keshan Disease primarily involves ensuring adequate selenium intake. This can be achieved through dietary diversification, selenium supplementation, and soil enrichment programs in affected regions. Public health initiatives aimed at raising awareness and improving nutrition can also play a significant role in prevention.

Keshan Disease is a selenium deficiency-related cardiomyopathy that can lead to severe heart failure if untreated. It is most common in regions with low selenium levels in the soil. Early diagnosis and treatment with selenium supplementation are crucial for improving outcomes. Preventive measures focus on ensuring adequate selenium intake through diet and supplementation.

For patients, understanding Keshan Disease involves recognizing its link to selenium deficiency and its impact on heart health. Symptoms like fatigue, shortness of breath, and swelling should prompt medical evaluation. Treatment with selenium supplements can be highly effective, especially when started early. Maintaining a balanced diet with adequate selenium is key to prevention, particularly in areas known for low soil selenium levels.